Signals of cell death and tissue turnover during physiological pregnancy, pre-eclampsia, and autoimmunity

Autoimmunity

Volumn 40, Issue 4, 2007, Pages 290-294

  Rovere Querini, Patrizia ^a   Castiglioni, Maria Teresa ^a   Sabbadini, Maria Grazia ^a   Manfredi, Angelo A ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Apoptosis; HMGB1; Pregnancy; PTX3

Indexed keywords

ALARMINS; CELL PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; PENTRAXIN 3; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOIMMUNITY; CELL ACTIVATION; CELL INFILTRATION; CONNECTIVE TISSUE DISEASE; ENDOTHELIUM CELL; HUMAN; INNATE IMMUNITY; LEUKOCYTE; NONHUMAN; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PREGNANCY; REVIEW; SIGNAL TRANSDUCTION; SMALL VESSEL VASCULITIS; THROMBOCYTE;

APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BLOOD PLATELETS; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNITY, NATURAL; LEUKOCYTES; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION; VASCULITIS;

EID: 34249821357     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930701358834     Document Type: Review

References (45)

1. Huang, FP, Platt, N., Wykes, M., Major, JR, Powell, TJ, Jenkins, CD and MacPherson, GG (2000) A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med, 191, pp. 435-444.
2. Skoberne, M., Beignon, AS, Larsson, M. and Bhardwaj, N. (2005) Apoptotic cells at the crossroads of tolerance and immunity. Curr Top Microbiol Immunol, 289, pp. 259-292.
3. Manfredi, AA, Sabbadini, MG and Rovere-Querini, P. (2005) Dendritic cells and the shadow line between autoimmunity and disease. Arthritis Rheum, 52, pp. 11-15.
4. Mahoney, JA and Rosen, A. (2005) Apoptosis and autoimmunity. Curr Opin Immunol, 17, pp. 583-588.
5. Munoz, LE, Gaipl, US, Franz, S., Sheriff, A., Voll, RE, Kalden, JR and Herrmann, M. (2005) SLE-a disease of clearance deficiency?. Rheumatology (Oxford), 44, pp. 1101-1107.
6. Herrmann, M., Voll, RE, Zoller, OM, Hagenhofer, M., Ponner, BB and Kalden, JR (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum, 41, pp. 1241-1250.
7. Baumann, I., Kolowos, W., Voll, RE, Manger, B., Gaipl, U., Neuhuber, WL, Kirchner, T., Kalden, JR and Herrmann, M. (2002) Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum, 46, pp. 191-201.
8. Rovere-Querini, P., Sabbadini, MG, Comite, G Di and Manfredi, AA (2006) Novel hints on the pathogenesis of lupus from in vivo models. Future Rheumatol, 1, pp. 217-224.
9. Manfredi, AA, Iannacone, M., D'Auria, F. and Rovere-Querini, P. (2002) The disposal of dying cells in living tissues. Apoptosis, 7, pp. 153-161.
10. Peng, Y., Kowalewski, R., Kim, S. and Elkon, KB (2005) The role of IgM antibodies in the recognition and clearance of apoptotic cells. Mol Immunol, 42, pp. 781-787.
11. Quartier, P., Potter, PK, Ehrenstein, MR, Walport, MJ and Botto, M. (2005) Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur J Immunol, 35, pp. 252-260.
12. Lewis, MJ and Botto, M. (2006) Complement deficiencies in humans and animals: Links to autoimmunity. Autoimmunity, 39, pp. 367-378.
13. Cohen, PL, Caricchio, R., Abraham, V., Camenisch, TD, Jennette, JC, Roubey, RA, Earp, HS, Matsushima, G. and Reap, EA (2002) Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med, 196, pp. 135-140.
14. Hanayama, R., Miyasaka, K., Nakaya, M. and Nagata, S. (2006) MFG-E8-dependent clearance of apoptotic cells, and autoimmunity caused by its failure. Curr Dir Autoimmun, 9, pp. 162-172.
15. Huppertz, B., Kadyrov, M. and Kingdom, JC (2006) Apoptosis and its role in the trophoblast. Am J Obstet Gynecol, 195, pp. 29-39.
16. Straszewski-Chavez, SL, Abrahams, VM and Mor, G. (2005) The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev, 26, pp. 877-897.
17. Bischoff, FZ, Lewis, DE and Simpson, JL (2005) Cell-free fetal DNA in maternal blood: Kinetics, source and structure. Hum Reprod Update, 11, pp. 59-67.
18. Abrahams, VM, Kim, YM, Straszewski, SL, Romero, R. and Mor, G. (2004) Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol, 51, pp. 275-282.
19. Trowsdale, J. and Betz, AG (2006) Mother's little helpers: Mechanisms of maternal-fetal tolerance. Nat Immunol, 7, pp. 241-246.
20. Redman, CW and Sargent, IL (2005) Latest advances in understanding preeclampsia. Science, 308, pp. 1592-1594.
21. Sibai, BM (2005) Diagnosis, prevention, and management of eclampsia. Obstet Gynecol, 105, pp. 402-410.
22. Moldenhauer, JS, Stanek, J., Warshak, C., Khoury, J. and Sibai, B. (2003) The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol, 189, pp. 1173-1177.
23. Feinberg, BB (2006) Preeclampsia: The death of Goliath. Am J Reprod Immunol, 55, pp. 84-98.
24. Rovere-Querini, P., Manfredi, AA and Sabbadini, MG (2005) Environmental adjuvants, apoptosis and the censorship over autoimmunity. Autoimmun Rev, 4, pp. 555-560.
25. Bottazzi, B., Garlanda, C., Salvatori, G., Jeannin, P., Manfredi, A. and Mantovani, A. (2006) Pentraxins as a key component of innate immunity. Curr Opin Immunol, 18, pp. 10-15.
26. Fazzini, F., Peri, G., Doni, A., Dell'Antonio, G., Cin, E Dal, Bozzolo, E., D'Auria, F., Praderio, L., Ciboddo, G., Sabbadini, MG, Manfredi, AA, Mantovani, A. and Rovere-Querini, P. (2001) PTX3 in small-vessel vasculitides: An independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum, 44, pp. 2841-2850.
27. Salustri, A., Garlanda, C., Hirsch, E., De Acetis, M., Maccagno, A., Bottazzi, B., Doni, A., Bastone, A., Mantovani, G., Peccoz, P Beck, Salvatori, G., Mahoney, DJ, Day, AJ, Siracusa, G., Romani, L. and Mantovani, A. (2004) PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development, 131, pp. 1577-1586.
28. Cetin, I., Cozzi, V., Pasqualini, F., Nebuloni, M., Garlanda, C., Vago, L., Pardi, G. and Mantovani, A. (2006) Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol, 194, pp. 1347-1353.
29. Rovere-Querini, P., Antonacci, S., Dell'Antonio, G., Angeli, A., Almirante, G., Cin, ED, Valsecchi, L., Lanzani, C., Sabbadini, MG, Doglioni, C., Manfredi, AA and Castiglioni, MT (2006) Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol, 108, pp. 148-155.
30. Assi, F., Fruscio, R., Bonardi, C., Ghidini, A., Allavena, P., Mantovani, A. and Locatelli, A. (2007) Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery. BJOG, 114, pp. 143-147.
31. Menon, R. and Fortunato, SJ (2004) The role of matrix degrading enzymes and apoptosis in rupture of membranes. J Soc Gynecol Investig, 11, pp. 427-437.
32. Rovere, P., Peri, G., Fazzini, F., Bottazzi, B., Doni, A., Bondanza, A., Zimmermann, VS, Garlanda, C., Fascio, U., Sabbadini, MG, Rugarli, C., Mantovani, A. and Manfredi, AA (2000) The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood, 96, pp. 4300-4306.
33. Baruah, P., Propato, A., Dumitriu, IE, Rovere-Querini, P., Russo, V., Fontana, R., Accapezzato, D., Peri, G., Mantovani, A., Barnaba, V. and Manfredi, AA (2006) The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells and edits the cross-presentation of self, viral and tumor antigens. Blood, 107, pp. 151-158.
34. Baruah, P., Dumitriu, IE, Peri, G., Russo, V., Mantovani, A., Manfredi, AA and Rovere-Querini, P. (2006) The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J Leukoc Biol, 80, pp. 87-95.
35. Oppenheim, JJ and Yang, D. (2005) Alarmins: Chemotactic activators of immune responses. Curr Opin Immunol, 17, pp. 359-365.
36. Bianchi, ME (2007) DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol, 81, pp. 1-5.
37. Scaffidi, P., Misteli, T. and Bianchi, ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 418, pp. 191-195.
38. Ulloa, L., Batliwalla, FM, Andersson, U., Gregersen, PK and Tracey, KJ (2003) High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis. Arthritis Rheum, 48, pp. 876-881.
39. Lotze, MT and Tracey, KJ (2005) High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol, 5, pp. 331-342.
40. Dumitriu, IE, Baruah, P., Manfredi, AA, Bianchi, ME and Rovere-Querini, P. (2005) HMGB1: Guiding immunity from within. Trends Immunol, 26, pp. 381-387.
41. Rovere-Querini, P., Capobianco, A., Scaffidi, P., Valentinis, B., Catalanotti, F., Giazzon, M., Dumitriu, IE, Müller, S., Iannacone, M., Traversari, C., Bianchi, ME and Manfredi, AA (2004) HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep, 5, pp. 825-830.
42. Messmer, D., Yang, H., Telusma, G., Knoll, F., Messmer, B., Tracey, KJ and Chiorazzi, N. (2004) High mobility group box protein 1: An endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol, 173, pp. 307-313.
43. Dumitriu, IE, Bianchi, ME, Bacci, M., Manfredi, AA and Rovere-Querini, P. (2007) The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol, 81, pp. 84-91.
44. Yang, D., Chen, Q., Yang, H., Tracey, KJ, Bustin, M. and Oppenheim, JJ (2007) High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol, 81, pp. 59-66.
45. Bell, CW, Jiang, W., Reich 3rd, CF and Pisetsky, DS (2006) The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol, 291, pp. C1318-C1325.